World's Best Scientists 2026 revealed!
Award Badge
Immunology
China
2026
Award Badge
Medicine
China
2023

D-Index & Metrics

Immunology

D-Index
128
Citations
58099
World Ranking
253
National Ranking
3

Medicine

D-Index
129
Citations
64521
World Ranking
2587
National Ranking
18

Xuetao Cao publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xuetao Cao sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 525 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xuetao Cao D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xuetao Cao sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 128 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in China Leader Award
  • 2025 - Research.com Immunology in China Leader Award
  • 2023 - Research.com Immunology in China Leader Award
  • 2023 - Research.com Medicine in China Leader Award
  • 2022 - Research.com Immunology in China Leader Award
  • 2022 - Research.com Medicine in China Leader Award
  • 2018 - Fellow of the American Academy of Arts and Sciences

Overview

Xuetao Cao is affiliated with Nankai University in China and has contributed extensively to the fields of biochemistry, genetics, molecular biology, immunology, microbiology, and medicine. Their research spans multiple subfields including immunology, molecular biology, cancer research, oncology, and infectious diseases.

The scientist's work has covered key topics such as interferon and immune responses, immune cell function and interaction, immune response and inflammation, immunotherapy and immune responses, cancer-related molecular mechanisms, RNA modifications and cancer, and the role of immune cells in cancer.

Frequent coauthors collaborating with Xuetao Cao include:

  • Bingjing Wang
  • Taoyong Chen
  • Yangyang Chai
  • Yizhi Yu
  • Xuan Zhang

Major venues for publication include:

  • Journal of Biological Chemistry
  • Signal Transduction and Targeted Therapy
  • Cancer Communications
  • Trends in Immunology
  • Proceedings of the National Academy of Sciences

Among the recent papers authored or coauthored by Xuetao Cao are:

  • "COVID-19: immunopathology and its implications for therapy" (2020), published in Nature Reviews. Immunology
  • "Dendritic cell migration in inflammation and immunity" (2021), published in Cellular and Molecular Immunology
  • "Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota" (2021), published in Signal Transduction and Targeted Therapy
  • "Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance" (2022), published in Cancer Cell
  • "Epigenetic Remodeling in Innate Immunity and Inflammation" (2021), published in Annual Review of Immunology

Xuetao Cao's research often intersects with cancer biology and immunology, with multiple publications focusing on cancer-related molecular mechanisms and immune system interactions with cancer cells.

In recognition of their scientific contributions, Xuetao Cao was named a Fellow of the American Academy of Arts and Sciences in 2018.

Best Publications

  • The ALICE experiment at the CERN LHC

    K. Aamodt;A. Abrahantes Quintana;R. Achenbach;S. Acounis

  • Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes

    Jing Guo;Fengming Huang;Jun Liu;Yu Chen

  • Characteristics and Significance of the Pre-metastatic Niche

    Yang Liu;Xuetao Cao;Xuetao Cao

  • Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.

    Dan Han;Jiangxue Li;Huamin Wang;Xiaoping Su

  • The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation.

    Pin Wang;Yiquan Xue;Yanmei Han;Li Lin

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β1

    Hequan Li;Yanmei Han;Qiuli Guo;Minggang Zhang

  • ALICE: Physics Performance Report, Volume II

    P. Cortese;G. Dellacasa;L. Ramello;M. Sitta

  • MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK2

    Jin Hou;Pin Wang;Li Lin;Xingguang Liu

  • Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

    Jin Hou;Li Lin;Weiping Zhou;Zhengxin Wang

  • Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.

    Qian Zhang;Kai Zhao;Qicong Shen;Yanmei Han

  • The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ.

    Feng Ma;Feng Ma;Sheng Xu;Xingguang Liu;Qian Zhang

  • Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease

    Xuetao Cao;Xuetao Cao

  • Post-Translational Modification Control of Innate Immunity

    Juan Liu;Cheng Qian;Xuetao Cao;Xuetao Cao

  • Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils.

    Yanfang Liu;Yan Gu;Yanmei Han;Qian Zhang

  • Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b

    Chaofeng Han;Jing Jin;Sheng Xu;Haibo Liu

  • B cells inhibit induction of T cell-dependent tumor immunity.

    Zhihai Qin;Günther Richter;Thomas Schüler;Sabrina Ibe

  • Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1

    Pin Wang;Jin Hou;Li Lin;Chunmei Wang

  • The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

    Pengyuan Yang;Huazhang An;Xingguang Liu;Mingyue Wen

  • Mettl3-mediated mRNA m 6 A methylation promotes dendritic cell activation.

    Huamin Wang;Xiang Hu;Xiang Hu;Xiang Hu;Mingyan Huang;Juan Liu

  • Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells

    Minghui Zhang;Hua Tang;Zhenhong Guo;Huazhang An

Frequent Co-Authors

Jianli Wang
Jianli Wang Zhejiang University
Liwei Lu
Liwei Lu University of Hong Kong
Hai Yu
Hai Yu University of California, Davis
Yang Liu
Yang Liu University of Michigan–Ann Arbor
Xiaoping Su
Xiaoping Su The University of Texas MD Anderson Cancer Center
Zhihai Qin
Zhihai Qin Chinese Academy of Sciences
Hirofumi Hamada
Hirofumi Hamada Sapporo Medical University
Zhigang Tian
Zhigang Tian University of Science and Technology of China
George F. Gao
George F. Gao Chinese Center For Disease Control and Prevention
Shengjun Wang
Shengjun Wang Jiangsu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can open diverse career pathways. Nursing remains a popular choice, often complementing immunology expertise by providing direct patient care and clinical insights. Many aspiring nurses consider programs like the accelerated nurse practitioner program to quickly advance their credentials and impact healthcare outcomes.

Non-nurses looking to enter the nursing field can benefit significantly from the best online BSN programs for non nurses. These provide a comprehensive pathway into nursing, making it easier to apply immunology knowledge in a clinical setting.

For those seeking a faster route, the easiest ABSN programs to get into offer accelerated timelines without compromising quality. These programs are ideal for students who want to quickly transition into nursing careers while grounding their skills in strong scientific principles.

Additionally, the fastest and easiest LPN programs present a practical option for gaining entry-level nursing qualifications. These can serve as stepping stones for further specialization or supplement an immunology-focused background with valuable patient care experience.

Best Scientists Citing Xuetao Cao

Trending Scientists

Recently Published Articles